Results 141 to 150 of about 209,267 (264)

Radioactive Waste Management

open access: yes, 2007
This report provides an overview of the project's main findings and accomplishments over its five-year life. The authors hope that this summary will help make the valuable information collected and generated by the GEOTRAP project accessible to a ...
Geotrap Radionuclide Migration
core  

Development of improved analysis of radionuclide images of aerosol deposition

open access: yes, 2008
Over the last few years, there has been an increase in the clinical methods targeting the human tracheobronchial tree, both for therapeutic and diagnostic purposes.
Montesantos, Spyridon
core   +1 more source

Advanced MXene‐Based Multifunctional Nanoarchitecture Materials Engineered for Adsorptive Cleanup of Hazardous Radioactive Pollutants: A Comprehensive Critical Review

open access: yesAdvanced Materials Interfaces, Volume 13, Issue 19, 6 October 2026.
This work critically reviews MXenes as highly effective multifunctional nanomaterials for the adsorption of radio‐contaminants, demonstrating a remarkable adsorption capacity of up to 1376.75 mg/g and cyclic stability of 2–8 cycles, with complexation, electrostatic interactions, and the numerical strength of MXene active sites playing a key operational
Stephen Sunday Emmanuel   +1 more
wiley   +1 more source

Nanowires Reinforce Oriented Macroporous Aerogels for Rapid Uranium Removal from Acidic Radioactive Wastewater

open access: yesAdvanced Science, Volume 13, Issue 55, 5 October 2026.
A “reinforced concrete” structural aerogel with directional microchannels is engineered for rapid uranium capture. The interconnected architecture enables ultrafast water permeation, and the nanowire reinforcement yields a 70‐fold increase in mechanical strength.
Ze Liu   +8 more
wiley   +1 more source

ICOS‐ImmunoPET Monitors T Cell Activation After Combination Immune Checkpoint Blockade in a Mouse Model of Melanoma Brain Metastasis

open access: yesAdvanced Science, Volume 13, Issue 56, 9 October 2026.
ICOS‐immunoPET noninvasively visualizes activated T cells in melanoma brain metastases following combined anti‐PD‐1/anti‐CTLA‐4 therapy. Clinical translation of this imaging approach may improve patient stratification and treatment monitoring and serve as a quantitative imaging endpoint to support immunotherapy development and clinical trials in brain ...
Renesmee C. Kuo   +10 more
wiley   +1 more source

In Situ Self‐Assembled Molecular Fortifying Agent for Enhanced Retention and Therapeutic Efficacy of Radiopharmaceuticals

open access: yesAggregate, Volume 7, Issue 10, October 2026.
A molecular‐fortifying agent strategy based on in situ self‐assembly is developed to prolong tumor retention of radioligands. After tumor‐targeting, FAP‐α cleavage triggers nanofiber formation, presenting azide anchors for bioorthogonal capture of pre‐accumulated radioligands.
Daojia Liu   +7 more
wiley   +1 more source

Research and Advances in the Application of Phosphogypsum in Pavement Base Course and Subgrade: A Review

open access: yesApplied Research, Volume 5, Issue 5, October 2026.
This review highlights how pretreatment and optimized mixture design enable the use of phosphogypsum in pavement base courses and subgrades. Combining physical, chemical, or thermal treatment with suitable binders and solid wastes can improve engineering performance, durability, and environmental safety.
Chiyao Qu   +4 more
wiley   +1 more source

Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single‐Arm Phase II Study

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine and epithelial skin cancer. Somatostatin analogues, such as lanreotide, have shown efficacy in managing other neuroendocrine tumors. Retrospective studies suggest that lanreotide may induce partial response or disease stabilization in patients with advanced MCC.
Julie Charles   +23 more
wiley   +1 more source

Combined Active Bone Marrow‐Sparing Radiotherapy and Prophylactic PEG‐rhG‐CSF to Reduce Severe Neutropenia During Platinum‐Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Platinum‐doublet concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC) is frequently complicated by severe neutropenia. This Phase II trial investigated whether combining active bone marrow‐sparing (ABMS) radiotherapy with prophylactic pegylated recombinant human granulocyte colony‐stimulating factor (PEG ...
ShanBing Wang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy